AG
ADPT icon

Algert Global’s Adaptive Biotechnologies ADPT Stock Holding History

Algert Global’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83M Sell
131,830
-230,880
-64% -$3.54M 0.03% 740
2026
Q1 		$5.03M Sell
362,710
-521,661
-59% -$8.31M 0.08% 439
2025
Q4 		$14.4M Buy
884,371
+362,351
+69% +$5.91M 0.22% 105
2025
Q3 		$7.81M Buy
522,020
+356,677
+216% +$4.35M 0.13% 260
2025
Q2 		$1.93M Buy
165,343
+7,623
+5% +$69.2K 0.04% 645
2025
Q1 		$1.17M Sell
157,720
-272,794
-63% -$2.1M 0.03% 739
2024
Q4 		$2.58M Buy
430,514
+354,191
+464% +$1.95M 0.06% 519
2024
Q3 		$391K Buy
76,323
+12,000
+19% +$52.3K 0.01% 946
2024
Q2 		$233K Sell
64,323
-103,163
-62% -$327K 0.01% 1223
2024
Q1 		$538K Hold
167,486
– – 0.02% 756
2023
Q4 		$821K Sell
167,486
-156,959
-48% -$716K 0.03% 672
2023
Q3 		$1.77M Buy
324,445
+28,200
+10% +$186K 0.08% 405
2023
Q2 		$1.99M Sell
296,245
-72,750
-20% -$541K 0.09% 386
2023
Q1 		$3.26M Buy
368,995
+76,638
+26% +$676K 0.15% 193
2022
Q4 		$2.23M Buy
292,357
+58,609
+25% +$456K 0.12% 262
2022
Q3 		$1.66M Sell
233,748
-57,787
-20% -$544K 0.1% 338
2022
Q2 		$2.36M Buy
291,535
+181,559
+165% +$1.6M 0.18% 137
2022
Q1 		$1.53M Buy
+109,976
New +$1.73M 0.1% 335

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Algert Global's ADPT Position: Q2 2026 in Review

Algert Global reduced its Adaptive Biotechnologies (ADPT) stake by 64% in Q2 2026, selling an estimated $3.54M and leaving 131,830 shares worth $2.83M. The position accounts for 0.03% of the portfolio, ranked #740.

Algert Global first reported a position in ADPT in Q1 2022 and has held it in 18 quarters since. The position peaked at $14.4M in Q4 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Algert Global held 131,830 shares of Adaptive Biotechnologies worth $2.83M as of Q2 2026.
  • Algert Global sold 230,880 Adaptive Biotechnologies shares in Q2 2026, an estimated $3.54M.
  • Adaptive Biotechnologies made up 0.03% of Algert Global's portfolio in Q2 2026, its #740 holding.
  • Algert Global first reported a position in Adaptive Biotechnologies in Q1 2022 and has held it in 18 quarters since.
  • Algert Global's Adaptive Biotechnologies position peaked at $14.4M in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.